Skip to main content
Loading market data...
ETF Nasdaq USD

ProShares Ultra Nasdaq Biotechnology BIB

Issuer: ProShares SEC registrant: ProShares Trust Derivatives-based
Watch BIB (sign in) Add to portfolio (BIB) Set an alert for BIB Compare BIB with other ETFs Position size calculator for BIB at 113.14 USD

How position sizing works
Last price 113.14 USD Change: Up +6.05 Percent change: Up +5.65%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Net expense ratio
0.95%
Prospectus 7 Apr 2025
Net assets
$73.7M
As of 31 May 2026
Holdings
267
As of 31 May 2026
12-month distribution yield
0.20%
Quarterly
Asset class
Derivatives-based
From holdings

ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund listed on the Nasdaq in the United States, issued by ProShares. Its category is Derivatives-based. Its last price was US$113.14 on 20 Oct 2026. Its net expense ratio is 0.95% a year, from its prospectus dated 7 Apr 2025. It reported net assets of US$73.65 million as of 31 May 2026. Its latest holdings report lists 267 holdings as of 31 May 2026. Over the last 12 months it paid distributions of US$0.23 a unit, a 12-month distribution yield of 0.20%, paid quarterly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
1.14%
Net, after fee waivers or reimbursements
0.95%
Management fee
0.75%
Prospectus date
7 Apr 2025
Filed with the SEC
7 Apr 2025

Source: SEC prospectus risk/return data sets (opens in a new tab) Filed

Size and reporting

Net assets
$73,651,927
Total assets
$76,160,019
Holdings as of
31 May 2026
Report made public
28 Jul 2026 (58 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Source: SEC Form N-PORT (opens in a new tab) Filed

Top holdings

Largest 25 of 267 positions, as of 31 May 2026. Weight is the percent of net assets the fund reported.

BIB top holdings as of 31 May 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 Total Return Swap No identifier reported 7.35% $5.4M Equity derivatives United States USD
2 ProShares GENIUS Money Market ETF US74350P6916 6.80% $5.0M Other United States USD
3 Gilead Sciences, Inc. US3755581036 4.66% $3.4M Equity (common) United States USD
4 Vertex Pharmaceuticals, Inc. US92532F1003 4.65% $3.4M Equity (common) United States USD
5 Amgen, Inc. US0311621009 4.48% $3.3M Equity (common) United States USD
6 Total Return Swap No identifier reported 3.94% $2.9M Equity derivatives United States USD
7 Total Return Swap No identifier reported 3.26% $2.4M Equity derivatives United States USD
8 Regeneron Pharmaceuticals, Inc. US75886F1075 3.21% $2.4M Equity (common) United States USD
9 Total Return Swap No identifier reported 2.62% $1.9M Equity derivatives United States USD
10 Total Return Swap No identifier reported -2.36% -$1.7M Equity derivatives United States USD
11 Alnylam Pharmaceuticals, Inc. US02043Q1076 2.01% $1.5M Equity (common) United States USD
12 Revolution Medicines, Inc. US76155X1000 1.57% $1.2M Equity (common) United States USD
13 Biogen, Inc. US09062X1037 1.44% $1.1M Equity (common) United States USD
14 Repurchase Agreement No identifier reported 1.28% $945K Repurchase agreements United States USD
15 Illumina, Inc. US4523271090 1.25% $921K Equity (common) United States USD
16 United Therapeutics Corp. US91307C1027 1.22% $902K Equity (common) United States USD
17 Royalty Pharma plc Royalty Pharma plc, Class A GB00BMVP7Y09 1.20% $883K Equity (common) United Kingdom USD
18 Argenx SE US04016X1019 1.19% $878K Equity (common) Netherlands USD
19 Total Return Swap No identifier reported 1.18% $871K Equity derivatives United States USD
20 Insmed, Inc. US4576693075 1.16% $852K Equity (common) United States USD
21 Roivant Sciences Ltd. BMG762791017 1.08% $794K Equity (common) Bermuda USD
22 Incyte Corp. US45337C1027 0.97% $712K Equity (common) United States USD
23 Viatris, Inc. US92556V1061 0.94% $692K Equity (common) United States USD
24 Moderna, Inc. US60770K1079 0.94% $689K Equity (common) United States USD
25 Guardant Health, Inc. US40131M1099 0.85% $629K Equity (common) United States USD

Source: SEC Form N-PORT (opens in a new tab) Made public Holdings as of 31 May 2026

All 267 stored holdings

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Warning: Uses derivatives

Derivative contracts in this report have a combined notional amount of 136% of net assets. The weights here show each contract's reported value, not the exposure it creates.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 63.04%
Equity derivatives 16.01%
Other 6.80%
Repurchase agreements 3.14%
Short-term investment vehicles (cash funds) 0.81%

Country

Country by weight
CountryWeightBar
United States 79.81%
United Kingdom 1.72%
Netherlands 1.57%
Ireland 1.19%
Bermuda 1.08%
France 0.95%
Denmark 0.78%
Switzerland 0.75%
Canada 0.59%
Germany 0.55%
Cayman Islands 0.40%
Jersey 0.10%
Other (6) 0.32%

The country each issuer is assigned to in the report.

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 89.79%

The currency each holding is denominated in. Currency hedges are not netted off, so a hedged fund still shows its holdings' currencies.

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 45.46%
Health Technology 0.84%
Technology 0.44%

Partial coverage: sectors are known for 46.7% of net assets (74% of the fund's equity weight), the holdings matched by CUSIP or ticker to US stocks listed on this site. The rest is not assigned a sector.

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.2250
3 payments per unit
12-month yield
0.20%
Distributions only, not total return
Frequency
Quarterly
From the gaps between ex-dates
Latest ex-date
23 Sep 2026

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.2250) ÷ latest price ($113.14) × 100 = 0.20%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (12 payments)
BIB distributions per unit by ex-date
Ex-dateAmount per unit
23 Sep 2026$0.0830
25 Mar 2026$0.0070
24 Dec 2025$0.1350
24 Sep 2025$0.1810
25 Jun 2025$0.1710
26 Mar 2025$0.1310
23 Dec 2024$0.3960
25 Sep 2024$0.1530
26 Jun 2024$0.2650
20 Mar 2024$0.0400
20 Dec 2023$0.0380
22 Dec 2022$0.0200

Source: Yahoo Finance (opens in a new tab) Checked · 2 days ago Amounts are adjusted for later unit splits

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources
    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Region and currency: automatic

    Prices stay in each listing's own currency. Your currency is used for totals and for "≈" estimates at the daily reference rate. How this works

    Colour theme